Clinical Trial Update: Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a genetically-informed therapy for estrogen receptor-positive breast cancer after CDK4/6 inhibitor treatment is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Advanced Breast Cancer | Phase 2 | Status: RECRUITING